Carregant...
Rac GTPases as key regulators of p210-BCR-ABL-dependent leukemogenesis
Chronic myelogenous leukemia (CML) is a malignant disease characterized by expression of p210-BCR-ABL, the product of the Philadelphia chromosome. Survival of CML patients has been significantly improved with the introduction of tyrosine kinase inhibitors that induce long-term hematologic remissions...
Guardat en:
| Publicat a: | Leukemia |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4464749/ https://ncbi.nlm.nih.gov/pubmed/18354486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2008.71 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|